Clinical Trials Browser

Phase NA × Leukemia, Myeloid, Acute × Control Groups × Clear all

NCT06301425 2024-07-10

MRD Response-adapted Allo-HSCT for Adverse-risk AML

Phase NA Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT04240600 2020-09-03

HEMVEF

Phase NA Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute